Mark T. Moore v. HHS - Tdap, Guillain-Barré syndrome (2020)
Case summary [AI summaries can sometimes make mistakes]
Mark T. Moore filed a petition for compensation on August 28, 2018, alleging that the Tdap vaccine he received on August 9, 2017, caused him to develop Guillain-Barré syndrome (GBS).
He further alleged that he suffered residual effects from the GBS for more than six months. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused or aggravated Mr.
Moore's condition. The parties subsequently reached a joint stipulation, which was filed on September 23, 2020.
Special Master Christian J. Moran reviewed the stipulation and found it reasonable, adopting it as the decision of the Court.
The stipulation awarded Mr. Moore a lump sum payment of $107,000.00 as compensation for all damages.
The decision was issued on October 20, 2020. Petitioner was represented by Summer P.
Abel of the Law Offices of Leah V. Durant, PLLC, and respondent was represented by Christine M.
Becer of the United States Department of Justice. The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses involved in this case.
Theory of causation
Petitioner Mark T. Moore alleged that the Tdap vaccine administered on August 9, 2017, caused Guillain-Barré syndrome (GBS), an injury listed on the Vaccine Injury Table. Petitioner further alleged residual effects lasting more than six months. Respondent denied causation. The parties reached a stipulation, adopted by Special Master Christian J. Moran on October 20, 2020, awarding $107,000.00 for all damages. The theory of causation relied upon was that the Tdap vaccine caused GBS, consistent with the Vaccine Injury Table. The public decision does not detail the specific mechanism of injury, expert testimony, or the evidence considered beyond the stipulation.
Source PDFs
USCOURTS-cofc-1_18-vv-01317